Repro-Med Systems, Inc. (OTCMKTS:REPR) Director Joseph M. Jr. Manko acquired 30,652 shares of the firm’s stock in a transaction that occurred on Tuesday, October 30th. The stock was bought at an average cost of $1.48 per share, with a total value of $45,364.96. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Shares of Repro-Med Systems stock opened at $1.57 on Thursday. Repro-Med Systems, Inc. has a 52 week low of $0.56 and a 52 week high of $1.80.
Repro-Med Systems (OTCMKTS:REPR) last announced its quarterly earnings data on Monday, August 6th. The company reported $0.01 EPS for the quarter. The company had revenue of $4.50 million during the quarter.
Repro Med Systems, Inc designs, manufactures, and markets proprietary portable medical devices and supplies primarily for the ambulatory infusion market and emergency medical applications worldwide. The company offers mechanical infusion product FREEDOM infusion systems, which include the FREEDOM60 syringe infusion driver, the FreedomEdge syringe infusion driver, HIgH-Flo subcutaneous safety needle sets, RMS precision flow rate tubing, and RMS precision flow rate controller, as well as medical suction product RES-Q-VAC, a portable medical suction system.
Recommended Story: Asset Allocation and Your Retirement
Receive News & Ratings for Repro-Med Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Repro-Med Systems and related companies with MarketBeat.com's FREE daily email newsletter.